CIK 0000944809
- Accelerated filer
OPKO HEALTH, INC.
Sign in to watch- Ticker
- OPK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752402409
- Phone
- +1 305-575-4181
- Business address
- 4400 BISCAYNE BLVD., MIAMI, FL, 33137
- Former names
- EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,577
- in 1 filing
Net −$24,577. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-14 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +6,143 | $1.94 | $12K | 29,652,177 |
| 2019-06-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +20,000 | $1.92 | $38K | 29,552,177 |
| 2019-06-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +15,000 | $1.93 | $29K | 29,567,177 |
| 2019-06-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +14,900 | $1.94 | $29K | 29,582,077 |
| 2019-06-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +100 | $1.94 | $194 | 29,582,177 |
| 2019-06-12 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +15,000 | $1.83 | $27K | 29,532,177 |
| 2019-06-11 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +49,991 | $1.87 | $93K | 29,517,168 |
| 2019-06-11 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +9 | $1.87 | $17 | 29,517,177 |
Page 51 of 51 · 1,008 trades